4Ramage G, Walle K V, Wickes B L, et al. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofihns [ J ]. Antimicrob Agents Chemother, 2001,45 ( 9 ) : 2475. 被引量：1
5He M, Du M Q, Fan M W, et al. In vitro activity of cugenol against Candida albicans biofilms [ J ]. Mycopathologia, 2007, 163(3) :137. 被引量：1
6Ramage G, Wickes B L, Lopez-Ribot J L, et al. Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA) [J]. Mycopathologia, 2007,164(6) :301. 被引量：1
7Wei G X, Bobek L A. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole [ J]. J Antimicrob Chemother, 2004,53 (5) :750. 被引量：1
9Lopez-Ribot J L. Candida albicans biofilms: More than filamentation[J]. Curr Biol, 2005,15(12) :11453. 被引量：1
10Cafiso V. Bertuccio T, Santagati M, et al. Presence of the ica operen in clinical isolates of Staphylococcus epidermidis and its role in biofilm production [ J ]. Clinical Microbiol Infect, 2004, 10 (12) :1081. 被引量：1
2Macassey E,Dawes P. Biofilms and their role in otorhinolaryn- gological disease [J]. J Laryngol Otol,2008,122(12) : 1275-1278. 被引量：1
3Pate1 R. Biofilms and antimicrobial resistance[J]. Clin Orthop Related Re s, 2005,437:41-47. 被引量：1
4Samimi DB, Bielory BP, Miller D,et al. Microbiologic trends and biofilm growth on explanted periorbital biomaterials:a 30- year review [J]. Ophthal Plast Reconstr Surg,2013,29(5) :376- 381. 被引量：1
5Aboltins C, Dowsey MM, Peel T,et ak Early prosthetic hip joint infection treated with debridement, prosthesis retention and biofilm-active antibiotics : functional outcomes, quality of life and complications [J]. Intern Med J,2013,43 (7):810-815. 被引量：1
8Golovlev EL. The mechanism of formation of Pseudomonas aeruginosa biofilm, a type of structured population [J]. Mikro- biologiia, 2002,71 (3) : 293-300. 被引量：1
